← All stocks

TherapeuticsMD, Inc.

TXMD Net selling
CIK 0000025743 #4985 in the set updated 21 Sep 2026
Bought (120 mo)
$32.75M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.50M
$0.00 on a plan · $27.40M straight out of an exercise
Sold at will
$39.10M
14 of 73 sales
Net
−$33.75M
−$6.35M against sales at will

By person

21 insiders · 125 transactions
0.2×

Marlan D. Walker holds only 0.2 times base salary in stock. $123.00K of shares against $500.00K in salary for 2024.

Salary from the company's own proxy. The shares are what Marlan D. Walker last reported holding, valued at $1.67, the price Common Stock was last bought or sold at on the open market here, on 23 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Milligan John C.K. IV
Secretary/CEO of subsidiary
$472.70K (4)
$10.80M (17) scheduled
−$10.32M
5,335,076
46.09%
$8.91M
−1.1%
Rubric Capital Management LP entity
Director
$29.67M (9)
$38.66M (1)
−$8.98M
2,946,908
25.46%
$4.92M
+174.3%
Bernick Brian
Co-Chief Executive Officer
$127.70K (2)
$7.90M (18) scheduled
−$7.78M
6,567,243
56.74%
$10.97M
−2.1%
Finizio Robert G
CEO
$549.98K (7)
$7.72M (17) scheduled
−$7.17M
19,991,637
$33.39M
−2.0%
Collins Cooper C.
Director
$1.52M (8)
+$1.52M
60,516
0.5228%
$101.08K
Krassan Mitchell
Chief Strategy Officer
$676.92K (1) scheduled
−$676.92K
0
0.0000%
$0.00
Cartwright Daniel A
Chief Financial Officer
$376.80K (2) scheduled
−$376.80K
40,000
0.3456%
$66.81K
0.0%
Thompson Tommy G
Director
$145.37K (10)
+$145.37K
25,181
0.2176%
$42.06K
Russell Angus C.
Director
$126.60K (3)
+$126.60K
5,792
0.0500%
$9.67K
MUSING JULES A.
Director
$100.92K (1)
−$100.92K
4,022
0.0347%
$6.72K
Bisaro Paul
Director
$96.50K (2)
+$96.50K
5,922
0.0512%
$9.89K
DArecca James
Chief Financial Officer
$81.20K (1)
−$81.20K
123,830
1.07%
$206.83K
Walker Marlan D
Chief Executive Officer
$2.48K (3)
$75.60K (5)
−$73.12K
73,639
0.6362%
$123.00K
BORKOWSKI EDWARD
EVP, Operations
$46.02K (1)
−$46.02K
59,248
0.5119%
$98.96K
Donegan Michael C
Prin. Fin. and Acctg. Officer
$40.94K (7) scheduled
−$40.94K
61,853
0.5344%
$103.31K
Ling Karen
Director
$25.08K (1)
+$25.08K
4,591
0.0397%
$7.67K
Naughton Gail K
Director
$20.64K (1)
−$20.64K
8,500
0.0734%
$14.20K
Barlow Jane F
Director
$10.00K (1)
+$10.00K
3,144
0.0272%
$5.25K
Glickman Mark A
Co-Chief Executive Officer
$2.17K (1) scheduled
−$2.17K
1,294
0.0112%
$2.16K
CARROLL J MARTIN
Director
106,864
0.9233%
$178.49K
+968.6%
ZIEGLER JOSEPH
Principal Financial Officer
7,500
0.0648%
$12.53K
Insider
Date
Role
Action
Shares
Price
Amount
Thompson Tommy G
23 Dec 2025
Director
Buy
8,400
$1.67
$14.03K
Walker Marlan D
14 Apr 2025
Chief Executive Officer
Buy
490
$1.00
$489.27
Thompson Tommy G
14 Apr 2025
Director
Buy
325
$1.00
$325.59
Walker Marlan D
10 Apr 2025
Chief Executive Officer
Buy
1,167
$0.86
$1.00K
Walker Marlan D
9 Apr 2025
Chief Executive Officer
Buy
1,136
$0.87
$993.66
Collins Cooper C.
22 Aug 2024
Director
Buy
4,094
$1.73
$7.10K
Collins Cooper C.
21 Aug 2024
Director
Buy
1,200
$1.70
$2.04K
Rubric Capital Management LP
9 Dec 2022
10% owner
Buy indirect
14,825
$6.09
$90.28K
Rubric Capital Management LP
8 Dec 2022
10% owner
Buy indirect
300
$5.83
$1.75K
Rubric Capital Management LP
7 Dec 2022
10% owner
Buy indirect
20,113
$5.66
$113.89K
Rubric Capital Management LP
28 Oct 2022
10% owner
Buy indirect
7,000
$1,000.00
$7.00M
Rubric Capital Management LP
30 Sep 2022
10% owner
Buy indirect
7,000
$1,000.00
$7.00M
Rubric Capital Management LP
29 Jul 2022
10% owner
Buy indirect
15,000
$822.21
$12.33M
Rubric Capital Management LP
29 Jul 2022
10% owner
Buy indirect
565,000
$4.72
$2.67M
Rubric Capital Management LP
18 Jul 2022
10% owner
Buy indirect
17,688
$6.03
$106.66K
Rubric Capital Management LP
15 Jul 2022
10% owner
Buy indirect
64,892
$5.56
$360.80K
Collins Cooper C.
18 Nov 2021
Director
Buy
1,000,000
$0.58
$578.50K
Collins Cooper C.
18 Aug 2021
Director
Buy
900,000
$0.72
$648.00K
Collins Cooper C.
17 Aug 2021
Director
Buy
100,000
$0.77
$77.00K
Ling Karen
17 Aug 2021
Director
Buy
33,445
$0.75
$25.08K
Bisaro Paul
16 Aug 2021
Director
Buy
50,000
$0.79
$39.50K
Thompson Tommy G
13 Aug 2021
Director
Buy indirect
11,000
$0.87
$9.57K
Thompson Tommy G
14 May 2021
Director
Buy indirect
5,000
$1.06
$5.30K
Finizio Robert G
9 Jun 2020
CEO
Buy
25,000
$1.47
$36.75K
Finizio Robert G
9 Jun 2020
CEO
Buy
21,000
$1.41
$29.61K
Collins Cooper C.
9 Jun 2020
Director
Buy
47,500
$1.45
$68.88K
Collins Cooper C.
8 Jun 2020
Director
Buy
26,500
$1.45
$38.43K
Finizio Robert G
5 Jun 2020
CEO
Buy
20,000
$1.15
$23.00K
Finizio Robert G
5 Jun 2020
CEO
Buy
10,000
$1.16
$11.60K
Bisaro Paul
4 Jun 2020
Director
Buy
50,000
$1.14
$57.00K
Thompson Tommy G
4 Jun 2020
Director
Buy indirect
8,700
$1.13
$9.83K
Finizio Robert G
25 Oct 2019
CEO
Buy
72,000
$2.75
$198.00K
Bernick Brian
25 Oct 2019
Director
Buy
36,000
$2.75
$99.00K
Milligan John C.K. IV
25 Oct 2019
President/Secretary
Buy
72,000
$2.75
$198.00K
Milligan John C.K. IV
25 Oct 2019
President/Secretary
Buy
72,000
$2.75
$198.00K
Russell Angus C.
23 Aug 2019
Director
Buy
10,000
$2.77
$27.70K
Finizio Robert G
20 Aug 2019
CEO
Buy
35,000
$2.74
$95.90K
Milligan John C.K. IV
16 Aug 2019
President/Secretary
Buy indirect
10,000
$2.93
$29.30K
Russell Angus C.
15 Aug 2019
Director
Buy
10,000
$2.99
$29.90K
Russell Angus C.
14 Aug 2019
Director
Buy
25,000
$2.76
$69.00K
Milligan John C.K. IV
12 Aug 2019
President/Secretary
Buy indirect
15,000
$3.16
$47.40K
Barlow Jane F
12 Aug 2019
Director
Buy
3,144
$3.18
$10.00K
Finizio Robert G
9 Aug 2019
CEO
Buy
52,405
$2.96
$155.12K
Bernick Brian
9 Aug 2019
Director
Buy
10,000
$2.87
$28.70K
Thompson Tommy G
9 Aug 2019
Director
Buy indirect
5,000
$3.04
$15.20K
Thompson Tommy G
13 May 2019
Director
Buy indirect
2,400
$3.34
$8.02K
Collins Cooper C.
13 May 2019
Director
Buy
30,000
$3.33
$99.87K
Thompson Tommy G
21 Aug 2018
Director
Buy indirect
4,000
$5.53
$22.10K
Thompson Tommy G
8 Dec 2017
Director
Buy indirect
5,000
$6.21
$31.05K
Thompson Tommy G
30 Aug 2017
Director
Buy indirect
5,000
$5.99
$29.95K

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 59
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 11,352,412
Sales filed before the plan box existed 12
History held since 22 Dec 2016